By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.
Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.
Episode Details
EPISODE INFO
- Released
- May 29, 2025
- Duration
- 25m
- Channel
- No Priors
- Watch on YouTube
- ▶ Open ↗
EPISODE DESCRIPTION
In this episode of No Priors, Sarah and Elad unpack the current state of the AI market - whether it’s consolidating, what’s enabling or blocking key mergers, and where the most promising untapped opportunities lie, particularly in biotech. They also explore the rise of world models and how AI’s novel methods for understanding complex systems may ultimately reshape how humans approach discovery and problem-solving. Show Notes: 0:00 Is the AI market consolidating into clear winners? + the physics of the current landscape 7:01 Why more companies don’t merge (even when it makes sense) 10:09 Exploring biotech’s biggest commercial opportunities and the challenges founders face 17:14 Building world models 21:34 How AI is expanding the way humans reason, design, and evolve systems
SPEAKERS
Sarah Guo
hostElad Gil
host
EPISODE SUMMARY
In this episode of No Priors, featuring Sarah Guo and Elad Gil, No Priors Ep. 116 | With Sarah and Elad explores AI Markets Crystallize As Founders Face Consolidation And New Frontiers Sarah and Elad discuss how parts of the AI market are finally consolidating, with clearer early winners emerging in areas like coding assistants, customer success, and healthcare applications. They contrast these with still-open arenas such as sales, finance, accounting, and pharma, where the right product approach or model capabilities have yet to fully materialize. Elad argues that startup–startup mergers will increasingly be rational to better fight entrenched incumbents, while Sarah highlights cultural and status barriers to such moves. The conversation then pivots to under-explored biotech opportunities and to AI research frontiers like world models and reinforcement learning as pathways toward more capable agents and eventual AGI.
RELATED EPISODES
